Chemoinformaics analysis of 6,7- dimethyl aesculetin
| Molecular Weight | 206.197 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.117 | nRig | 12 |
| Exact Molecular Weight | 206.058 | nRing | 2 |
| Solubility: LogS | -2.094 | nHRing | 1 |
| Solubility: LogP | 1.38 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 28.2459 |
| nHD | 0 | BPOL | 16.1081 |
| QED | 0.703 |
| Synth | 1.858 |
| Natural Product Likeliness | 0.547 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.019 |
| Pgp-sub | 0.128 |
| HIA | 0.005 |
| CACO-2 | -4.656 |
| MDCK | 0.0000313 |
| BBB | 0.498 |
| PPB | 0.664831 |
| VDSS | 0.882 |
| FU | 0.256596 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.968 |
| CYP2c19-inh | 0.319 |
| CYP2c19-sub | 0.624 |
| CYP2c9-inh | 0.034 |
| CYP2c9-sub | 0.855 |
| CYP2d6-inh | 0.178 |
| CYP2d6-sub | 0.906 |
| CYP3a4-inh | 0.085 |
| CYP3a4-sub | 0.475 |
| CL | 11.015 |
| T12 | 0.814 |
| hERG | 0.203 |
| Ames | 0.117 |
| ROA | 0.072 |
| SkinSen | 0.322 |
| Carcinogencity | 0.496 |
| EI | 0.898 |
| Respiratory | 0.069 |
| NR-Aromatase | 0.182 |
| Antiviral | No |
| Prediction | 0.688709 |